Enzymatic antioxidant balance and cognitive decline in aging - The EVA study

被引：24

作者：

Berr C. ^{[1
,2
,4
]}

Richard M.-J. ^{[3
]}

Gourlet V. ^{[1
]}

Garrel C. ^{[3
]}

Favier A. ^{[3
]}

机构：

[1] INSERM U360, Rech. Epidemiologique en Neurologie, Hopital de la Salpetriere, París

[2] INSERM E0361, Pathologies du Systeme Nerveux, Hôpital La Colombiere, Montpellier

[3] Lab. de Biologie du Stress Oxydant, Université de Grenoble I, La Tronche

[4] INSERM E0361, Hôpital La Colombiere, Pavillon. 42, 34093 Montpellier Cedex 5

来源：

European Journal of Epidemiology | 2004年 / 19卷 / 2期

关键词：

Cognition; Dementia; Glutathion peroxidase; Oxidative stress; Superoxide dismutase;

D O I：

10.1023/B:EJEP.0000017830.27594.e9

中图分类号：

学科分类号：

摘要：

We studied whether primary enzymatic antioxidant protection should influence cognitive decline (CD) in subjects aged 62-72 years volunteers in the Etude du Vieillissement Antériel (EVA) cohort. At baseline, we measured red blood cells activities of two enzymes: cytoplasmic form of superoxide dismutase (CuZn-SOD) and seleno dependent glutathione peroxidase (GSH-Px). During the 4 year-follow up (follow-up rate of 81%), a drop of at least 3 points in MMSE score was observed in 71 subjects (7.2%) defining individuals with CD+ among the 980 individuals. Initial GSH-Px activity appeared to be significantly lower in individual CD+ (41.2 ± 10.3 U/g Hb vs. 44.4 ± 9.4 in CD-, p = 0.008). Conversely, there was an increase of CuZn-SOD activity in CD+ subjects (1.13 ± 0.10 U/mg Hb vs. 1.10 ± 0.10,p = 0.05). Taking into account the ratio between these two levels suggest that the equilibrium between these two enzymes, an important determinant of oxidative stress level, is associated with CD. These results are independent of other potential risk factors for CD (education, Apolipoprotein E, hypertension) and suggest that this primary enzymatic system could be related to CD during aging.

引用

页码：133 / 138

页数：5

共 20 条

[1] Witztum J.L., The oxidation hypothesis of atherosclerosis, Lancet, 344, pp. 793-795, (1994)
[2] Beal M.F., Aging, energy, and oxidative stress in neurodegenerative diseases, Ann Neurol, 38, pp. 357-366, (1995)
[3] Beckman K.B., Ames B.N., The free radical theory of aging matures, Physiol Rev, 78, pp. 547-581, (1998)
[4] Sinet P.M., Metabolism of oxigen derivatives in Down's syndrome, Ann NY Acad Sci, 396, pp. 83-94, (1982)
[5] De La Monte S.M., Molecular abnormalities of the brain in Down syndrome: Relevance to Alzheimer's neurodegeneration, J Neural Transm Suppl, 57, pp. 1-19, (1999)
[6] Markesbery W.R., The role of oxidative stress in Alzheimer disease, Arch Neurol, 56, pp. 1449-1452, (1999)
[7] Berr C., Richard M.J., Roussel A.M., Bonithon-Kopp C., Systemic oxidative stress and cognitive performance in the population-based EVA study, Free Radical Biol Med, 24, pp. 1202-1208, (1998)
[8] Berr C., Coudray C., Bonithon-Kopp C., Roussel A.M., Mainard F., Alperovitch A., Demographic and cardiovascular risk factors in relation to antioxidant status: The EVA Study, Int J Vitam Nutr Res, 68, pp. 26-35, (1998)
[9] Bachman D.L., Wolf A.P., Linn R.T., Et al., Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study, Neurology, 43, pp. 515-519, (1993)
[10] Berr C., Dufouil C., Brousseau T., Et al., Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: The EVA study, Neurosci Lett, 218, pp. 9-12, (1996)

← 1 2 →